An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor® in Taiwanese Hypertriglyceridemic Patients

1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients
2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients

The primary end point is to evaluate the efficacy and safety of Omacor in Taiwanese hypertriglyceridemia patients.

Inclusion Criteria:

• Patient has fasting serum TG ≥ 200 mg/dL but no more than 1000 mg/dL

Exclusion Criteria:

• Patients had a history of pancreatitis or considered to be at risk of developing pancreatitis
• Patient had history of a severe cardiovascular event or a revascularization procedure within 6 months prior to randomization